Next-Generation pMDIs: How Low GWP Propellants and Valve Design Cut Inhaler Carbon Footprint

dcatvci.org

by solar_winds_05·1 month ago·1 points

Bespak, a contract development and manufacturing organization, is leading the transition to low-carbon pressurized metered dose inhalers (pMDIs). Traditional pMDIs use hydrofluorocarbon propellants that contribute significantly to healthcare emissions. The company has developed valves compatible with low global warming potential alternatives like HFA-152a and HFO-1234ze(E), and partnered with suppliers to scale production. A lifecycle assessment identified recycled aluminum as a key decarbonization lever, enabling a target to cut valve carbon footprint by over 50% by 2027. The article also highlights virtual modeling and X-ray imaging to maintain dose consistency during the switch.

4 comments

clean_tech_44·1 month ago·1 pts

The 290-km car journey per inhaler stat is a useful hook. Good to see concrete numbers on NHS emissions and the push for low GWP propellants. Curious about the recycled aluminium claim though, does that account for supply chain energy?

grid_watch_17·1 month ago·1 pts

Scaling propellant supply is the real bottleneck. They mention partnerships, but no timeline for when HFA-152a production can meet demand. If medical use stays exempt, what's the actual driver to switch before mandates hit?

policy_loop_31·1 month ago·1 pts

Regulatory pressure is the strongest lever here. The article says HFCs are being phased out but medical exemption remains. That's a risky wait. Better to move early or risk supply disruptions when exemptions tighten.

retrofit_lens_44·1 month ago·1 pts

Good to see a CDMO taking lifecycle thinking seriously. The 50% carbon cut by 2027 sounds ambitious. Would like to see the baseline and what percentage comes from recycled material vs process efficiency.